R. Gibb

发表

Identification of a Unique Form of p53 in Human Cord Blood Associated with the Development of Maternal Autoantibodies

C. Gerçel-Taylor, C. Yashar, R. Gibb, 1998, American journal of reproductive immunology.

Apoptosis as a measure of chemosensitivity to cisplatin and taxol therapy in ovarian cancer cell lines.

R. Gibb, D. Taylor, T. Wan, 1997, Gynecologic oncology.

Prognostic factors associated with response in platinum retreatment of platinum-resistant ovarian cancer

D. Mutch, J. Rader, R. Gibb, 2007, International Journal of Gynecologic Cancer.

Increased risk for abnormalities on perioperative colon screening in patients with microsatellite instability–positive endometrial carcinoma

P. Goodfellow, D. Mutch, R. Gibb, 2006, International Journal of Gynecologic Cancer.

Colposcopic accuracy of obstetrics and gynecology residents.

Jason D. Wright, D. Mutch, J. Rader, 2006, Gynecologic oncology.

Synchronous ovarian metastases at the time of laparotomy for colon cancer.

Jason D. Wright, D. Mutch, J. Rader, 2004, Gynecologic oncology.

Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms.

Jason D. Wright, D. Mutch, J. Rader, 2004, Gynecologic oncology.

Teleoncology for gynecologic cancers.

R. Gibb, M. Bell, D. Shalowitz, 2015, Gynecologic oncology.

Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer.

D. Mutch, J. Rader, B. Siegel, 2002, Gynecologic oncology.

Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer.

Jason D. Wright, P. Grigsby, D. Mutch, 2006, Gynecologic oncology.

The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.

D. Mutch, R. Gibb, T. Herzog, 2004, Gynecologic oncology.

Body mass index: relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer.

P. Goodfellow, K. Trinkaus, D. Mutch, 2007, Gynecologic oncology.

Prognostic impact of clinical tumor size on overall survival for subclassifying stages I and II vaginal cancer: A SEER analysis.

R. Gibb, A. Wolfson, I. Reis, 2016, Gynecologic oncology.

Long-term outcome of women who undergo panniculectomy at the time of gynecologic surgery.

Jason D. Wright, D. Mutch, J. Rader, 2006, Gynecologic oncology.

Utility of parametrectomy for early stage cervical cancer treated with radical hysterectomy

Jason D. Wright, P. Grigsby, D. Mutch, 2007, Cancer.

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

P. Goodfellow, E. Swisher, D. Mutch, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy

P. Grigsby, D. Mutch, J. Rader, 2006, Radiation Medicine.

Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer

P. Grigsby, D. Mutch, J. Rader, 2007, Radiation Medicine.

We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies.

W. Cliby, M. Spillman, L. Havrilesky, 2013, Gynecologic oncology.

Utility and Cost‐Effectiveness of Preoperative Autologous Blood Donation in Gynecologic and Gynecologic Oncology Patients

D. Mutch, J. Rader, R. Gibb, 2002, Obstetrics and gynecology.

Morbidity of Cytoreductive Surgery in the Elderly

Jason D. Wright, D. Mutch, J. Rader, 2003, American journal of obstetrics and gynecology.

Inhibition of Endometrial Cancer Cell Lines by Mifepristone (RU 486)

Douglas D. Taylor, R. Gibb, T. Wan, 1998, The Journal of the Society for Gynecologic Investigation: JSGI.

Use of diphenylamine in the detection of apoptosis.

R. Gibb, Ç. Gerçel-Taylor, 2001, Methods in molecular medicine.

Lymphokine‐Activated Killer (LAK)‐Mediated Lysis of Sequentially Isolated Ovarian Cancer Cell Lines

C. Yashar, R. Gibb, D. Taylor, 1997, American journal of reproductive immunology.

Cervical sarcomas: an analysis of incidence and outcome.

Jason D. Wright, D. Mutch, J. Rader, 2005, Gynecologic oncology.

DNA mismatch repair and TP53 defects are early events in uterine carcinosarcoma tumorigenesis

P. Goodfellow, D. Mutch, J. Rader, 2006, Modern Pathology.

Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer

R. Gibb, L. Parker, Joan L. Walker, 2015, Cancer.

Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history.

P. Goodfellow, D. Mutch, J. Rader, 2004, American journal of human genetics.

CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan.

D. Mutch, J. Rader, R. Gibb, 2006, Gynecologic oncology.

Phase II evaluation of a 3-day infusion of topotecan in patients with recurrent ovarian or primary peritoneal cancer.

D. Mutch, J. Rader, R. Gibb, 2006, Gynecologic oncology.

Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type.

P. Goodfellow, D. Mutch, J. Rader, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer.

P. Grigsby, D. Mutch, J. Rader, 2007, Gynecologic oncology.

Preoperative lymph node staging of early‐stage cervical carcinoma by [18F]‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography

P. Grigsby, D. Mutch, J. Rader, 2005, Cancer.

The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies.

D. Mutch, J. Rader, R. Gibb, 2002, Gynecologic oncology.

Cervical Dysplasia in Adolescents

D. Mutch, J. Rader, R. Gibb, 2005, Obstetrics and gynecology.

MLH3 mutation in endometrial cancer.

S. Thibodeau, P. Goodfellow, D. Mutch, 2006, Cancer research.

Human papillomavirus type and tobacco use as predictors of survival in early stage cervical carcinoma.

D. Gerhard, K. Trinkaus, D. Mutch, 2005, Gynecologic oncology.

Cervical carcinoma in the elderly

P. Grigsby, K. Trinkaus, D. Mutch, 2005, Cancer.

Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.

P. Grigsby, D. Mutch, J. Rader, 2004, Gynecologic oncology.

FDG-PET evaluation of vaginal carcinoma.

P. Grigsby, D. Mutch, J. Rader, 2005, International journal of radiation oncology, biology, physics.

Frequent HOXA11 and THBS2 promoter methylation, and a methylator phenotype in endometrial adenocarcinoma.

P. Goodfellow, D. Mutch, J. Rader, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Frequent HOXA 11 and THBS 2 Promoter Methylation , and a Methylator Phenotype in Endometrial Adenocarcinoma 1

P. Goodfellow, D. Mutch, J. Rader, 2003 .

CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer.

P. Grigsby, D. Gerhard, I. Borecki, 2007, Cancer research.

CD 83 Gene Polymorphisms Increase Susceptibility to Human Invasive Cervical Cancer

P. Grigsby, D. Gerhard, I. Borecki, 2007 .

Bevacizumab combination therapy in recurrent, platinum‐refractory, epithelial ovarian carcinoma

D. Mutch, J. Rader, R. Gibb, 2006, Cancer.

ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes.

Matthew A Powell, Feng Gao, P. Goodfellow, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Resource utilization for ovarian cancer patients at the end of life: how much is too much?

D. Mutch, J. Rader, R. Gibb, 2005, Gynecologic oncology.

Increased Risk for Hereditary Nonpolyposis Colorectal Cancer-Associated Synchronous and Metachronous Malignancies in Patients with Microsatellite Instability-Positive Endometrial Carcinoma Lacking MLH1 Promoter Methylation

P. Goodfellow, D. Mutch, J. Rader, 2004, Clinical Cancer Research.

A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer

A. Berchuck, K. Trinkaus, D. Mutch, 2007, International Journal of Gynecologic Cancer.

The impact of liquid-based cytology in decreasing the incidence of cervical cancer.

R. Gibb, M. Martens, Randall K Gibb, 2011, Reviews in obstetrics & gynecology.

Taxol-induced bcl-2 phosphorylation in ovarian cancer cell monolayer and spheroids.

R. Gibb, D. Taylor, S Makhija, 1999, International journal of oncology.

Human Papillomavirus Triage for Young Women With Atypical Squamous Cells of Undetermined Significance

D. Mutch, J. Rader, R. Gibb, 2006, Obstetrics and gynecology.

The Impact of Liquid-Based Cytology

R. Gibb, M. Martens, 2011 .

Phase II evaluation of topotecan and navelbine in patients with recurrent ovarian, fallopian tube or primary peritoneal cancer.

D. Mutch, J. Rader, R. Gibb, 2008, Gynecologic oncology.

Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomas.

P. Goodfellow, D. Mutch, R. Gibb, 2006, Gynecologic oncology.

Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis.

D. Mutch, R. Gibb, T. Herzog, 2007, Gynecologic oncology.

Ovarian cancer patient surveillance after curative-intent initial treatment.

D. Mutch, R. Gibb, Katherine S. Virgo, 2011, Gynecologic oncology.

Relationship of ovarian neoplasms and body mass index.

D. Mutch, J. Rader, R. Gibb, 2005, Journal of reproductive medicine.

Bevacizumab therapy in patients with recurrent uterine neoplasms.

D. Mutch, J. Rader, R. Gibb, 2007, Anticancer research.

Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma.

P. Grigsby, D. Mutch, J. Rader, 2007, International journal of radiation oncology, biology, physics.

Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients

D. Mutch, J. Rader, R. Gibb, 2002 .

Endometrial stromal sarcoma involving the placenta.

R. Gibb, D. O'connor, W. Katsanis, 1998, Annals of diagnostic pathology.

Liquid-based cytology for the postirradiation surveillance of women with gynecologic malignancies.

D. Mutch, J. Rader, R. Gibb, 2003, Gynecologic oncology.

Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.

P. Goodfellow, D. Mutch, J. Rader, 2002, Gynecologic oncology.

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial

J. Manson, R. Vierkant, T. Sellers, 2005, JAMA.

Ovary, Fallopian Tube, and Primary Peritoneal Carcinoma

D. Mutch, P. Bhosale, R. Gibb, 2017 .